olivLaw · US equity research
Waterdrop Inc. WDH
Insurance Agents, Brokers & Service · SIC 6411 · Vertical: Insurance Agents, Brokers & Service (SIC 6411)
Waterdrop Inc. is a Chinese technology platform focused on insurance and healthcare services with a social impact, earning mainly brokerage and technical service fees. Its revenue grew sharply in 2025, driven largely by technical services provided to insurers, which has drawn attention to its business model. The company operates in a heavily regulated sector where regulatory change could directly affect its growth.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, Waterdrop Inc. (WDH) stock was 1.01 USD (+1.00% on the day), with market capitalisation 3.6 bn USD, P/E 50.5 on diluted EPS of 0.02 USD over the last 12 months, dividend yield 0.51%, beta 0.78, 52-week range 0.97–1.95 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 47.0
- neutral
- Bollinger (20, 2)
- 0.99 – 1.04
- in the lower half of the band · %B 0.44 · band width 5.3%
- SMA 50 / 200
- 1.02 / 1.45
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.01 / -0.01
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −1.9% | −1.1% | −0.8 pp | — |
| 3 months | +1.0% | −0.5% | +1.5 pp | — |
| 6 months | −36.5% | +4.4% | −40.9 pp | — |
| Year to date | −46.8% | +12.3% | −59.2 pp | — |
| 1 year | −39.5% | +13.5% | −53.1 pp | +0.8% |
| 3 years | −11.0% | +76.4% | −87.4 pp | +4.3% |
| 5 years | −51.2% | +63.7% | −114.9 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 0 percentile of its own 4-quarter history (min 95.0, median 111.0, max 166.5; quarters with earnings only).
Fiscal years
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | unavailable | 503.1 m | 406.2 m | 370.5 m | 379.7 m | 568.8 m |
| Revenue YoY | unavailable | unavailable | −19.3% | −8.8% | +2.5% | +49.8% |
| Net income | unavailable | -247.0 m | 88.1 m | 23.1 m | 48.1 m | 80.8 m |
| Net income YoY | unavailable | unavailable | unavailable | −73.8% | +108.5% | +68.1% |
| Diluted EPS | unavailable | unavailable | 0.02 | 0.01 | 0.01 | 0.02 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | −50.0% | 0.0% | +100.0% |
| net % | unavailable | -49.1% | 21.7% | 6.2% | 12.7% | 14.2% |
| Free cash flow | unavailable | -177.7 m | 109.3 m | 55.4 m | 30.0 m | 30.6 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 69.1 m USD
- Financial debt
- 6.7 m USD
- Net debt
- -62.3 m USD
- Equity
- 736.7 m USD
- Total assets
- 1.0 bn USD
- Debt / equity
- 0.01x
- Current ratio
- 2.10x
- ROE
- 11.6%
- ROA
- 8.5%
- FCF margin
- 5.4%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|
| Revenue | 503.1 m | 406.2 m | 370.5 m | 379.7 m | 568.8 m | SEC (XBRL)· 28 Apr 2026verified |
| Research & development | 59.5 m | 42.2 m | 42.1 m | 29.7 m | 33.3 m | SEC (XBRL)· 28 Apr 2026verified |
| Operating income | -292.3 m | 69.3 m | -950.0 k | 24.4 m | 53.0 m | SEC (XBRL)· 28 Apr 2026verified |
| Pre-tax income | -281.7 m | 91.4 m | 23.1 m | 49.4 m | 77.7 m | SEC (XBRL)· 28 Apr 2026verified |
| Income tax | -34.7 m | 3.3 m | 78.0 k | 1.3 m | -3.1 m | SEC (XBRL)· 28 Apr 2026verified |
| Net income | -247.0 m | 88.1 m | 23.1 m | 48.1 m | 80.8 m | SEC (XBRL)· 28 Apr 2026verified |
| Diluted EPS | — | 0.02 | 0.01 | 0.01 | 0.02 | SEC (XBRL)· 28 Apr 2026verified |
| Weighted average diluted shares | 3.0 bn | 4.0 bn | 3.9 bn | 3.7 bn | 3.7 bn | SEC (XBRL)· 28 Apr 2026verified |
Balance sheet · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|
| Cash | 128.3 m | 228.2 m | 55.9 m | 135.1 m | 69.1 m | SEC (XBRL)· 28 Apr 2026verified |
| Receivables | 101.0 m | 98.0 m | 97.6 m | 98.1 m | 180.2 m | SEC (XBRL)· 28 Apr 2026verified |
| Current assets | 789.8 m | 825.1 m | 764.3 m | 635.4 m | 569.2 m | SEC (XBRL)· 28 Apr 2026verified |
| Property, plant & equipment, net | 7.0 m | 4.6 m | 4.8 m | 32.9 m | 36.6 m | SEC (XBRL)· 28 Apr 2026verified |
| Goodwill | 537.0 k | 496.0 k | 11.4 m | 11.1 m | 11.5 m | SEC (XBRL)· 28 Apr 2026verified |
| Intangibles (excl. goodwill) | 8.9 m | 8.2 m | 25.0 m | 21.0 m | 25.3 m | SEC (XBRL)· 28 Apr 2026verified |
| Total assets | 823.9 m | 858.6 m | 866.0 m | 884.1 m | 1.0 bn | SEC (XBRL)· 28 Apr 2026verified |
| Short-term debt | — | — | 19.4 m | 27.2 m | 6.7 m | SEC (XBRL)· 28 Apr 2026verified |
| Current liabilities | 196.0 m | 162.6 m | 192.9 m | 203.4 m | 270.6 m | SEC (XBRL)· 28 Apr 2026verified |
| Total liabilities | 200.4 m | 167.6 m | 207.1 m | 216.5 m | 278.7 m | SEC (XBRL)· 28 Apr 2026verified |
| Equity | 623.5 m † | 691.0 m † | 645.9 m † | 657.2 m † | 736.7 m † | SEC (XBRL)· 28 Apr 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|
| Operating cash flow | -172.1 m | 111.0 m | 57.3 m | 59.9 m | 34.9 m | SEC (XBRL)· 28 Apr 2026verified |
| Capex | 5.6 m | 1.7 m | 1.9 m | 29.9 m | 4.2 m | SEC (XBRL)· 28 Apr 2026verified |
| Free cash flow | -177.7 m ≈ | 109.3 m ≈ | 55.4 m ≈ | 30.0 m ≈ | 30.6 m ≈ | SEC (XBRL)· 28 Apr 2026derived |
| Investing cash flow | -132.9 m | -20.3 m | -165.2 m | 40.0 m | -32.1 m | SEC (XBRL)· 28 Apr 2026verified |
| Financing cash flow | 332.6 m | -8.3 m | -53.1 m | -27.2 m | -53.5 m | SEC (XBRL)· 28 Apr 2026verified |
| Dividends paid | — | — | — | 21.7 m | 18.6 m | SEC (XBRL)· 28 Apr 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 40 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 3.6 bn USD
Key indicators
Coverage and freshness
Score by group
- Balance sheet100
- Growth49
- Quality47
- Returns38
- Valuation13
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 0.30 – 0.73 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/E0.30 – 0.73 (Mid 0.44)11 companies used · median multiple 22.1x · quartiles 14.8x – 36.3xACT, AJG, AON, BRO, CRVL, GSHD, MRSH, RYAN, SLQT, TWFG, WTW
- Dividend discount (DDM)unavailable · input data missing
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Neutral profile · Score 40/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 7.3% | 50 (vs peers) | 14% |
| Net margin · Quality | 14.2% | 76 (vs peers) | 9% |
| FCF conversion · Quality | 37.9% | 11 (on a fixed band) | 9% |
| Revenue CAGR 3Y · Growth | 11.9% | 99 (on a fixed band) | 11% |
| EPS CAGR 3Y · Growth | 0.0% | 0 (on a fixed band) | 11% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 2.1x | 100 (on a fixed band) | 6% |
| P/E (TTM) · Valuation | 50.5x | 15 (vs peers) | 14% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 0.8% | 11 (on a fixed band) | 11% |
| Shareholder yield (distributions) · Returns | 0.5% | 7 (on a fixed band) | 9% |
| Payout ratio (FCF) · Returns | 60.9% | 84 (on a fixed band) | 6% |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial100/100 · 1/3 factors with a value
- Growth49/100 · 2/2 factors with a value
- Quality47/100 · 3/3 factors with a value
- Returns38/100 · 2/2 factors with a value
- Valuation13/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Waterdrop Inc. (WDH). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: revenue 568.8 m USD in 2025; YoY growth 49.8%; net margin 14.2%; ROE 11.6%.
The estimated value range is 0.30–0.73 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 0.44 USD, the price of 1.01 USD leaves a potential of -56.3% (value / price − 1) and a margin of safety of -128.8% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 40/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: balance. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: 14.2%
- Revenue CAGR 3Y: 11.9%
- Current ratio: 2.1x
- Payout ratio (FCF): 60.9%
What contradicts it
- FCF conversion: 37.9%
- EPS CAGR 3Y: 0.0%
- P/E (TTM): 50.5x
- FCF yield: 0.8%
- Shareholder yield (distributions): 0.5%
- The price is above the estimated value range
Not assessed (insufficient data or a ratio without meaning): Net debt / EBITDA, Interest coverage, EV/EBITDA.
Versus the vertical median
Insurance Agents, Brokers & Service (SIC 6411) · same industry (4-digit SIC) · compared with 29 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| MRSHMarsh & Mclennan Companies, Inc. | 100.0 bn | 25.2 | 26.7% | 14.2% | +10.3% | +15% / +5% |
| XHGXChange TEC.INC | 85.9 bn | — | — | -204.9% | +24.9% | +253% / −100% |
| AJGArthur J. Gallagher & Co. | 73.9 bn | 47.1 | 6.7% | 10.0% | +20.7% | +16% / +16% |
| AONAon plc | 73.1 bn | 18.9 | 43.6% | 22.2% | +9.4% | −3% / +5% |
| WTWWillis Towers Watson PLC | 31.1 bn | 20.5 | 20.2% | 15.2% | −2.2% | +5% / +37% |
| BROBrown & Brown, Inc. | 24.5 bn | 22.1 | 9.7% | 17.6% | +22.8% | −8% / −1% |
| EQHEquitable Holdings, Inc. | 15.3 bn | — | -508.8% | -8.7% | −6.1% | +20% / +83% |
| AIFUAIFU Inc. | 10.5 bn | — | -155.9% | -408.8% | −67.9% | −84% / −100% |
| ACTEnact Holdings, Inc. | 6.6 bn | 10.7 | 12.7% | 53.8% | +2.8% | +25% / +74% |
| HGTYHagerty, Inc. | 6.5 bn | 108.0 | 25.6% | 4.4% | +17.3% | +40% / +121% |
| RYANRyan Specialty Holdings, Inc. | 5.2 bn | 49.9 | 19.4% | 3.2% | +21.3% | −18% / +4% |
| CRVLCorvel Corporation | 4.4 bn | 38.9 | 30.7% | 11.7% | +7.0% | +19% / +26% |
| WDHWaterdrop Inc. | 3.6 bn | 50.5 | 11.6% | 14.2% | +49.8% | −40% / −11% |
| ARXAccelerant Holdings | 3.3 bn | — | -241.6% | -112.1% | +51.5% | +36% / unavailable |
| NPNeptune Insurance Holdings Inc. | 2.7 bn | 91.6 | — | 22.7% | +33.7% | +22% / unavailable |
| GSHDGoosehead Insurance, Inc. | 1.2 bn | 33.8 | — | 8.8% | +16.2% | −21% / −23% |
| HUIZHuize Holding Limited | 1.1 bn | — | 1.0% | 0.3% | +32.2% | −31% / −48% |
| BWINThe Baldwin Insurance Group, Inc. | 1.1 bn | — | -10.7% | -4.7% | +8.3% | +13% / +84% |
| RDZNRoadzen Inc. | 92.8 m | — | — | -46.9% | +24.2% | −37% / −78% |
| SLQTSelectQuote, Inc. | 88.1 m | 7.3 | 23.4% | 4.6% | +6.0% | −66% / −61% |
| EHTHeHealth, Inc | 20.3 m | — | 5.0% | 5.4% | +4.1% | −84% / −91% |
| EZRAReliance Global Group, Inc. | 2.4 m | — | -123.4% | -54.3% | −11.6% | −91% / −100% |
| YBYuanbao Inc. | — | — | 152.7% | 29.9% | +33.1% | −43% / unavailable |
| ERIEErie Indemnity Company | — | — | 23.7% | 14.0% | +7.2% | −5% / −5% |
| HITHealth In Tech, Inc. | — | — | -21.9% | -12.0% | +71.0% | −61% / unavailable |
1- and 3-year price returns: for WDH from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 0.72 Total return -29% · Per year -29% | 1.26 Total return 25% · Per year 25% | 1.90 Total return 88% · Per year 88% |
| 3 years | 0.80 Total return -20% · Per year -7% | 1.58 Total return 57% · Per year 16% | 2.59 Total return 157% · Per year 37% |
| 5 years | 0.90 Total return -11% · Per year -2% | 1.98 Total return 96% · Per year 14% | 3.54 Total return 251% · Per year 29% |
- Exit P/E± 0.40
- Net margin± 0.28
- Annual revenue growth± 0.21
- Annual dilution± 0.02
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 28 Apr 2026; since then the company filed 6-K (08 Sept 2026), 6-K (24 Jul 2026), 6-K (23 Jun 2026), 6-K (17 Jun 2026).
In brief
Waterdrop Inc. is a Chinese technology platform focused on insurance and healthcare services with a social impact, earning mainly brokerage and technical service fees. Its revenue grew sharply in 2025, driven largely by technical services provided to insurers, which has drawn attention to its business model 1. The company operates in a heavily regulated sector where regulatory change could directly affect its growth.
SWOT
Strengths
- A large consumer base, an extensive network of partner insurers and the ability to negotiate favorable terms are clear strengths 1.
- Co-developed products can reach the market very quickly and are generally exclusive to the platform, which strengthens partner relationships 1.
- Investment in AI has allowed business growth to be decoupled from headcount growth, supporting the scalability of the model 1.
Weaknesses
- The company has a relatively short operating history and its business model has changed frequently, which makes future performance hard to assess 1.
- Technical service income grew sharply but may fluctuate significantly, so its long-term stability is not assured 1.
- The VIE structure through which China operations are consolidated exposes investors to legal and contract enforcement risks 1.
Opportunities
- Low awareness of health insurance in China leaves room to grow the number of enrolled consumers 1.
- Products for people with pre-existing conditions could open segments not served by traditional health insurance 1.
- Patient recruitment services for clinical trials could become an additional revenue source if demand from the pharmaceutical industry grows 1.
Threats
- Regulatory changes in China can alter the rules for insurance and crowdfunding quickly, with direct effects on the business model 1.
- The entry of large internet companies into healthcare and insurance services could reduce the platform's market share 1.
- Rival crowdfunding platforms offering free services could attract patients and donors away from the company 1.
Risks
- Regulatory riskhigh
Changes to rules for insurance brokerage and crowdfunding could directly affect the company's activity and revenue 1.
- VIE structurehigh
Investors hold shares in a Cayman Islands holding company rather than in the China operating entities, and authorities could challenge the contractual arrangements 1.
- Intense competitionmedium
New or existing competitors could reduce market share and pressure commissions and user acquisition costs 1.
- Return on new technologylow
AI investments might not translate into commercial results, and the legal framework for this technology remains uncertain 1.
Investment thesis
What would need to be true (bull case)
- If the consumer base and technical service income keep growing, the company could strengthen its position as a leading insurance platform in China 1.
- If AI tools sustain their productivity effect, margins could benefit from the scalability of the model 1.
- Low insurance awareness in China could provide a long-term growth market for the company 1.
What would break the thesis
- If regulation tightens or the VIE structure is challenged, the business model could be seriously affected 1.
- Recent growth in technical service income may be volatile, so future results could be weaker 1.
- If large competitors expand their offerings, the company could lose users and be forced to cut prices or commissions 1.
What to watch
- Development of technical service income from insurers2026
- Number of paying consumers and first year premium per consumerQ1 2027
- Any regulatory change for medical crowdfunding2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 28 Apr 2026; since then the company filed 6-K (08 Sept 2026), 6-K (24 Jul 2026), 6-K (23 Jun 2026), 6-K (17 Jun 2026).
The business
Waterdrop Inc. operates in three areas: insurance brokerage and agency through Waterdrop Insurance Marketplace and Shenlanbao Insurance Marketplace, the Waterdrop Medical Crowdfunding platform for medical costs, and digital patient recruitment solutions for clinical trials 1. It earns commissions on premiums paid by consumers, service fees on crowdfunding withdrawals, and technical service income from insurers and brokers 1. It works with 103 insurance carriers and has served 123.4 million cumulative insurance consumers, of which 38.9 million were paying consumers 1.
The insurance segment includes both marketplaces, long-term insurance advisory services and technical services such as risk assessment and customer relationship management 1. In 2025 the company launched AI tools including KEYI.AI and Waterdrop Sea.AI for underwriting and AI agent development 1. In December 2024 Waterdrop Medical Crowdfunding was designated by the Ministry of Civil Affairs as a personal help-seeking online service platform, which strengthened its regulatory standing 1.
The company was founded in 2016 and has been listed on the New York Stock Exchange under WDH since May 2021; its China operations run through consolidated VIEs, and investors hold shares in a Cayman Islands holding company rather than in the operating entities 1. This structure carries specific legal risks that the company describes in its filing 1.
Market context
The company competes in China's insurance brokerage market, which is intensely competitive and undergoing rapid change as insurers demand more digital integration and data analytics 1. Insurance awareness in China remains well below developed markets, leaving room for growth in online platforms 1. The medical crowdfunding market is also evolving under regulation and the coverage of social medical insurance 1.
Trends
- Digitalization of insurance distributiontailwind
Insurers increasingly require digital support, data analytics and efficient distribution, while consumers prefer seamless online experiences and transparent comparisons 1. Providers able to deliver these capabilities could benefit from stronger demand.
- Artificial intelligence in operationsmixed
The company uses AI for underwriting, advisory and customer service, which has supported higher productivity per employee 1. If these tools prove effective they could support long-term margins, though the required investment is also significant 1.
- Regulation of crowdfundingmixed
Since December 2024 the platform has held official status as a personal help-seeking service, which could bring a more stable framework, but regulatory changes could alter its fee model and growth 1.
- Rising competitive pressureheadwind
The entry of large internet platforms and new players into online brokerage or healthcare services could reduce the company's market share and pressure commissions 1.
Competitive position
The company names Ant Group and WeSure as online competitors and Mingya and Datong as offline competitors, alongside traditional channels such as bancassurance and insurers' direct sales 1. Many players are entering medical crowdfunding, and competition in healthcare services is also intense 1.
The company says its advantages come from its large consumer base, its carrier network and its technical capabilities, but it acknowledges that new competitors can emerge at any time 1. If it cannot adapt its model quickly, it could lose market share 1.
- Ant Group
Online insurance brokerage competitor named by the company in its filing 1.
- WeSure
Online insurance platform identified as a direct competitor in online brokerage 1.
- Mingya
Offline insurance broker and agent mentioned as a competitor in the traditional channel 1.
- Datong
Offline insurance broker and agent mentioned as a competitor in the traditional channel 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Waterdrop Q2 Earnings Call HighlightsYahoo Finance — News · 08 Sept 2026 · EN
- Compania austriacă waterdrop încheie un parteneriat cu chef-ul Yannick Alléno pentru dezvoltarea brandului în industria ospitalitățiiEconomedia · 03 Aug 2026 · RO
- De la o idee schiţată într-un avion la un brand global: ce a învăţat Waterdrop despre generaţia ta? „Gen Z poate detecta lipsa de autenticitate imediat”Ziarul Financiar · 10 Jun 2026 · RO
SEC filings
- Current report (foreign issuer)08 Sept 2026
- Current report (foreign issuer)24 Jul 2026
- Current report (foreign issuer)23 Jun 2026
- Current report (foreign issuer)17 Jun 2026
- Annual report (foreign issuer)28 Apr 2026
- Current report (foreign issuer)25 Mar 2026
- Current report (foreign issuer)03 Dec 2025
- Current report (foreign issuer)03 Dec 2025
- Current report (foreign issuer)04 Sept 2025
- Current report (foreign issuer)05 Jun 2025
Sources
- [1] Form 20-F, fiscal year ended 2025-12-31 · SEC / Waterdrop Inc. · 28 Apr 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.